ASSESSMENT OF BLOOD MARKERS AFTER RADIONUCLIDE THERAPY FOR OSTEOGENIC METASTASIS OF KIDNEY AND PROSTATE CANCER . World Bulletin of Public Health, [S. l.], v. 12, p. 66–69, 2022. Disponível em: https://www.scholarexpress.net/index.php/wbph/article/view/1135. Acesso em: 18 apr. 2026.